Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 31 Dec 2014  |  North America

    US Liquid Handling Market

    Strategies to Drive Growth in an Increasingly Competitive Market

    The total market, as defined by this study, includes automated robotic workstations, low-to-mid throughput automated tools, and manual pipettes and consumables in the United States. The study period runs from 2011 to 2021, with 2014 as base year of 2014 and 20152021 as forecast period. This research service offers a discussion of the key market dr...

    $3,950.00
  2. 30 Dec 2014  |  North America

    2015 Global Laboratory Products Purchasing Trends

    End-user Perspective

    Readers of the Lab Manager Magazine were invited to participate in an online survey in September 2014. To qualify for survey participation, readers were required to play a role in their laboratory’s purchasing process, be familiar with their laboratories’ product budgets, and represent a laboratory that either uses or plans to use products in o...

    $6,950.00
  3. 29 Dec 2014  |  Global

    Emerging Trends in Cell Banking (Technical Insights)

    Trends in Master and Working Cell Baking

    The execution of different test methods aiming to evaluate the stability and potency of biopharmaceutical products, as well as, their pharmacokinetic/pharmacodynamic (PK/PD) profiles, their characterization and comparison with other drugs, or the detection of antidrug antibodies (ADAs) or neutralizing antibodies (NAB), represent critical stages in ...

    $3,950.00
  4. 19 Dec 2014  |  Asia Pacific

    Patent Cliff and the Future of Generics in Asia

    Trends that will Impact the Market in the Short Term

    The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a signi...

    $2,450.00
  5. 16 Dec 2014  |  North America

    US Self-monitoring Blood Glucose Market

    Reimbursement cutback, and competitive bidding program for mail order supplies, will restrain the SMBG market until 2016

    This market insight focuses on the developments in the self-monitoring blood glucose market in the United States. Reimbursement analysis and the effects of competitive bidding have been studied. Thorough product analyses for more than 73 SMBG meters have been performed, based on the various features of differentiation. The market insight discusses ...

    $3,950.00
  6. 16 Dec 2014  |  Europe

    The Russian Biopharmaceuticals and Biomedicine Market

    From Import Substitution to Innovation

    This study explores Western Europes dynamic next generation sequencing (NGS) market. The majority of the quantitative and qualitative information was acquired through primary research conducted with NGS providers. The market is broadly classified into 2 major segments: instruments and reagents, and 2 subsegments: research use only and clinical dia...

    $1,500.00
  7. 15 Dec 2014  |  North America

    Next-generation Healthcare - Global Advanced Medical Technologies 2014

    Disruptions and Transformations are Shaping the Future of Healthcare Delivery

    This study analyzes trends impacting the future of healthcare delivery and market participants. Market solutions are transitioning from models suited to older citizens for use type service models toward business models built around value and quality of service. Companies with solutions around specific procedures or treatments could see attrition as...

    $3,950.00
  8. 05 Dec 2014  |  North America

    US Hemostasis Market

    Increase in the Number of Patients within the Healthcare System Triggers Reagent Market Growth

    The Affordable Care Act has created an upswing in the number of patients entering the US healthcare system, boosting the volume of routine and specialized testing performed in laboratories. This market insight analyzes the instrumentation and reagent segment activity within the US hemostasis market. Key trends and a comparative analysis between the...

    $2,450.00
  9. 21 Nov 2014  |  North America

    Analysis of the US LIMS Market

    Pharmaceuticals and Biobanks Spur Market Revenue with Increasing Adoption of Thin-client Web-based Systems

    The laboratory information management systems (LIMS) market in the United States has been a mature space for many years. The evolution of laboratory needs has spurred innovation in this industry, forcing vendors to change their approach toward consumers. Consumers have the option of choosing between thick-client (Web-enabled) solutions, thin-client...

    $3,950.00
  10. 20 Nov 2014  |  North America

    Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market

    Launch of Novel Oral Therapies to Result in Major Market Changes

    This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study cov...

    $3,950.00